REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 10 filers reported holding REGENERON PHARMACEUTICALS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,419,784 | -35.7% | 47,900 | -43.8% | 0.01% | -38.1% |
| Q2 2023 | $61,291,462 | +19.0% | 85,300 | +36.0% | 0.02% | 0.0% |
| Q1 2023 | $51,518,709 | -4.5% | 62,700 | -16.2% | 0.02% | -16.0% |
| Q4 2022 | $53,967,452 | +22.0% | 74,800 | +16.5% | 0.02% | +31.6% |
| Q3 2022 | $44,225,000 | +0.3% | 64,200 | -13.9% | 0.02% | 0.0% |
| Q2 2022 | $44,098,000 | – | 74,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IMC-Chicago, LLC | 73,100 | $35,315,000 | 0.04% |
| GROUP ONE TRADING, L.P. | 46,700 | $22,561,000 | 0.04% |
| SIMPLEX TRADING, LLC | 365 | $17,633,000 | 0.02% |
| SG Americas Securities, LLC | 19,200 | $2,212,000 | 0.01% |
| JPMORGAN CHASE & CO | 22,500 | $10,870,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |